Updated Jul 16, 2026
Pieper Steven has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $383K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | XERS | Xeris Biopharma Holdings, Inc. | S — Open-market sale | 27.6K | $8.52 | $235K |
| 2026-07-07 | XERS | Xeris Biopharma Holdings, Inc. | S — Open-market sale | 17.4K | $8.50 | $148K |
| 2026-03-06 | XERS | Xeris Biopharma Holdings, Inc. | M — Option exercise | 14.0K | $5.93 | $83K |
| 2026-03-06 | XERS | Xeris Biopharma Holdings, Inc. | M — Option exercise | 27.9K | $4.09 | $114K |
| 2026-02-02 | XERS | Xeris Biopharma Holdings, Inc. | F — Tax withholding / forfeiture | 27.3K | $7.36 | $201K |
| 2026-02-02 | XERS | Xeris Biopharma Holdings, Inc. | F — Tax withholding / forfeiture | 66.5K | $7.36 | $489K |
| 2026-02-02 | XERS | Xeris Biopharma Holdings, Inc. | F — Tax withholding / forfeiture | 111.8K | $7.36 | $823K |
| 2026-02-02 | XERS | Xeris Biopharma Holdings, Inc. | A — Grant or award | 155.0K | $0.00 | |
| 2024-11-26 | XERS | Xeris Biopharma Holdings, Inc. | M — Option exercise | 19.5K | $1.55 | $30K |
Pieper Steven is a corporate insider — currently tracked as See Remarks of Xeris Biopharma Holdings, Inc. (XERS). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($383K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Pieper Steven profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.